Newsletter Subscribe
Enter your email address below and subscribe to our newsletter
Research & Studies
Share your love
How to Slow The Myopia In Children With Contact Lenses
Myopia, or short-sightedness, is one of the most common eye health issues in children and means that they can’t see objects that are far away, causing their vision to blur. Symptoms usually appear between the ages of 8 and 12…
The Basics of Excimer Laser
In the field of ophthalmology, laser technology is used in many basic and clinical disciplines and specialities. It has played an important role in promoting the development of ophthalmology. Advancements in technology have allowed improvements in the surgical safety, efficacy, speed…
Slowing The Myopia In Children With Contact Lenses
Are you prescribing contact lenses for myopia management? We ask this question at the start of every myopia management lecture we deliver. Over the past two years, we have gone from having audiences with no hands raised to now having…
Nanoscope Announces Positive Results in RP Treatment
Nanoscope Therapeutics announced positive topline results from the phase 2b RESTORE trial, evaluating MCO-010, a novel gene therapy aimed at treating severe vision loss caused by advanced retinitis pigmentosa (RP), irrespective of the genetic mutation causing the disease. RESTORE Trial…
Regeneron’s High-Dose Aflibercept Receives FDA Approval
Regeneron has received FDA approval for Eylea HD (aflibercept 8 mg) in a significant development anticipated to substantially extend dosing intervals for patients with retinal diseases such as wet age-related macular degeneration (AMD), diabetic macular edema (DME), and diabetic retinopathy (DR).…
FDA Rejects Lytenava by Outlook Therapeutics for Wet AMD
Outlook Therapeutics announced that the FDA has issued a complete response letter (CRL) regarding the company’s Biologics License Application (BLA) for ONS-5010 (Lytenava). ONS-5010 is an investigative ophthalmic formulation of bevacizumab aimed at treating wet AMD. While the FDA recognized…
Scientists Develop AI to Help Doctors Pick Best IOL Option
Scientists have developed computer models of patients’ eyes to determine the most suitable intraocular lenses and to offer patients a visual simulation of their expected vision with these lenses. Although millions of individuals have undergone LASIK eye surgery since it…
Ectopia Lentis: Causes, Symptoms, and Management
Ectopia lentis is a term that holds a pivotal place within the realm of ophthalmology, shedding light on a unique condition that involves the lens of the eye. This condition, characterized by the displacement or dislocation of the lens from…
What Is Bullous Keratopathy and How to Manage It
What Is Bullous Keratopathy? Bullous keratopathy (BK) is a pathological condition characterized by the presence of fluid-filled blisters or “bullae” on the cornea, which is the clear front surface of the eye. The main underlying factor leading to the formation…
LumiThera Receives $2.3M NIH Grant for Dry AMD Trial
LumiThera has been granted a small business innovative research (SBIR) phase 2 grant from the National Institute of Health (NIH), totaling up to $2.3 million in funding over a span of 2 years. This NIH/NEI grant is geared towards supporting…